OBJECTIVE: To investigate the endocrinological and endometrial factors in women with unexplained recurrent miscarriage DESIGN: Prospective, case study SETTING: Recurrent miscarriage clinic, Jessop Hospital for Women, Sheffield PARTICIPANTS: One hundred and forty-four women with unexplained recurrent (> or =3) miscarriages METHODS: A blood sample was obtained in early follicular phase (day 3-5) to measure follicle stimulating hormone, luteinising hormone, prolactin, androgens and thyroid function; daily blood/urine samples were obtained from mid-follicular phase to measure luteinising hormone until the luteinising hormone surge was identified; endometrial biopsy and a further blood sample for progesterone measurement were obtained in the mid-luteal phase. A transvaginal ultrasonography was performed to evaluate ovarian morphology. RESULTS: Hypersecretion of luteinising hormone or ultrasonographic features of polycystic ovarian disease was present in 8% and 7.8% of women, respectively. The free androgen index was elevated in 14.6% of subjects. In the mid-luteal phase, low progesterone level was found in 17.4% and delayed endometrial development was noted in 27.1% of women. Although women with recurrent miscarriage women and delayed endometrium had significantly lower progesterone levels than those with normal endometrial development, only 8/24 had mid-luteal progesterone levels below 30 nmol/L. Recurrent miscarriage was not associated with hyperprolactinaemia or abnormal thyroid function test. CONCLUSIONS: Endocrinological and endometrial abnormalities are present in about a quarter of women with unexplained recurrent miscarriage.
OBJECTIVE: To investigate the endocrinological and endometrial factors in women with unexplained recurrent miscarriage DESIGN: Prospective, case study SETTING: Recurrent miscarriage clinic, Jessop Hospital for Women, Sheffield PARTICIPANTS: One hundred and forty-four women with unexplained recurrent (> or =3) miscarriages METHODS: A blood sample was obtained in early follicular phase (day 3-5) to measure follicle stimulating hormone, luteinising hormone, prolactin, androgens and thyroid function; daily blood/urine samples were obtained from mid-follicular phase to measure luteinising hormone until the luteinising hormone surge was identified; endometrial biopsy and a further blood sample for progesterone measurement were obtained in the mid-luteal phase. A transvaginal ultrasonography was performed to evaluate ovarian morphology. RESULTS: Hypersecretion of luteinising hormone or ultrasonographic features of polycystic ovarian disease was present in 8% and 7.8% of women, respectively. The free androgen index was elevated in 14.6% of subjects. In the mid-luteal phase, low progesterone level was found in 17.4% and delayed endometrial development was noted in 27.1% of women. Although women with recurrent miscarriage women and delayed endometrium had significantly lower progesterone levels than those with normal endometrial development, only 8/24 had mid-luteal progesterone levels below 30 nmol/L. Recurrent miscarriage was not associated with hyperprolactinaemia or abnormal thyroid function test. CONCLUSIONS: Endocrinological and endometrial abnormalities are present in about a quarter of women with unexplained recurrent miscarriage.
Authors: Arri Coomarasamy; Hoda M Harb; Adam J Devall; Versha Cheed; Tracy E Roberts; Ilias Goranitis; Chidubem B Ogwulu; Helen M Williams; Ioannis D Gallos; Abey Eapen; Jane P Daniels; Amna Ahmed; Ruth Bender-Atik; Kalsang Bhatia; Cecilia Bottomley; Jane Brewin; Meenakshi Choudhary; Fiona Crosfill; Shilpa Deb; W Colin Duncan; Andrew Ewer; Kim Hinshaw; Thomas Holland; Feras Izzat; Jemma Johns; Mary-Ann Lumsden; Padma Manda; Jane E Norman; Natalie Nunes; Caroline E Overton; Kathiuska Kriedt; Siobhan Quenby; Sandhya Rao; Jackie Ross; Anupama Shahid; Martyn Underwood; Nirmala Vaithilingham; Linda Watkins; Catherine Wykes; Andrew W Horne; Davor Jurkovic; Lee J Middleton Journal: Health Technol Assess Date: 2020-06 Impact factor: 4.014
Authors: Tien Huu Nguyen; Martin S Lennard; Cyrus Ghobadi; Amin Rostami-Hodjegan; William L Ledger Journal: J Assist Reprod Genet Date: 2006-12-03 Impact factor: 3.412
Authors: Daniel M Green; Vikki G Nolan; Toana Kawashima; Marilyn Stovall; Sarah S Donaldson; DeoKumar Srivastava; Wendy Leisenring; Leslie L Robison; Charles A Sklar Journal: Fertil Steril Date: 2011-03-03 Impact factor: 7.329
Authors: Mary A Andrews; Karen C Schliep; Jean Wactawski-Wende; Joseph B Stanford; Shvetha M Zarek; Rose G Radin; Lindsey A Sjaarda; Neil J Perkins; Robyn A Kalwerisky; Ahmad O Hammoud; Sunni L Mumford Journal: Hum Reprod Date: 2015-06-16 Impact factor: 6.918
Authors: Anna A Pendina; Olga A Efimova; Olga G Chiryaeva; Andrei V Tikhonov; Lubov' I Petrova; Vera S Dudkina; Natalia A Sadik; Irina D Fedorova; Ilona A Galembo; Tatyana V Kuznetzova; Alexander M Gzgzyan; Vladislav S Baranov Journal: J Assist Reprod Genet Date: 2013-12-10 Impact factor: 3.412
Authors: Hady El Hachem; Vincent Crepaux; Pascale May-Panloup; Philippe Descamps; Guillaume Legendre; Pierre-Emmanuel Bouet Journal: Int J Womens Health Date: 2017-05-17